Article
Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
20 Jun 2011
Abstract excerpt
BACKGROUND: Mucopolysaccharidosis type III (MPS III, Sanfilippo syndrome) is a lysosomal storage disorder caused by a deficiency of one of the enzymes involved in the degradation of heparan sulfate. MPS III is characterized by progressive mental deterioration resulting in severe dementia. A number of potentially disease-modifying therapies are studied. As preservation of cognitive function is the ultimate goal of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
